Home drug plan design

Keyword: drug plan design

86 results found
Copyright_aberheide_123RF

An article on legal challenges filed against the federal government’s hybrid work mandate for public service employees was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Unions representing federal public service workers file legal challenges against hybrid work mandate 2. Expert […]

  • By: Staff
  • May 31, 2024 May 30, 2024
  • 09:00
Copyright_peopleimages12 _!23RF

Amid a wave of frank and open discussions about women’s health, more plan sponsors are beginning to review their benefits and human resources policies with an eye to providing better support. It’s something that a group of health-care experts, speaking during a panel discussion at Benefits Canada’s 2024 Chronic Disease at Work conference in February, […]

Copyright_atlasfoto_123RF

After her husband Mike Kessler was diagnosed with mild Alzheimer’s disease in 2021, Karen Kessler admitted she would hover around him. The Windsor, Ont. couple implemented many strategies in place to manage Mike’s diagnosis, and Karen remembers believing he would need plenty of help. “I was doing everything, I was carrying the load, and quite […]

Copyright_svershinsky_123RF

With the increased availability of treatments for inflammatory bowel disease, patients can achieve longer periods of remission, said Vipul Jairath, a gastroenterologist at the London Health Sciences Centre and professor of medicine at Western University, during Benefits Canada’s 2024 Chronic Disease at Work conference in February. IBD involves an underlying pathological process that creates inflammation […]

A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director of private payers and investment, during a session at Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The survey noted private payer review times can take […]

Pharmacists are now uniquely positioned to support Canadians at a time when the public health-care system is stretched thin, creating significant barriers for people looking to access care, said Dr. Jennifer Poh, senior director of drug plan solutions at Health Solutions by Shoppers, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in […]

With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate health support and employee satisfaction while also being cost effective, said Marie-Hélène Dugal, manager of pharmacy benefit strategy for Medavie Blue Cross, during Benefits Canada’s 2023 Face to Face Drug […]

Despite the safety and efficacy of biosimilars — and the potential cost savings they offer — uptake among private payers has been low historically and is only starting to gain steam, said Neda Nasseri, pharmacist and private payer product director at Desjardins Insurance, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The insurer first developed […]

It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing common hurdles within their own drug plans, said John Adams, chair of the board of directors for patient advocacy group Best Medicines Coalition, during a session at Benefits Canada’s 2023 Face […]

The 10 highest-cost drugs reimbursed by public drug plans in Canada in the 2021/22 fiscal year were all rare disease treatments with annual treatment costs of more than $250,000, according to a new report by the Patented Medicine Prices Review Board. It found the increased use of high-cost drugs continued to be the main factor […]